Mankind Pharma Limited — Credit Ratings, 16-01-2026: Credit Rating
16-01-2026 | 06:25 pm
16-01-2026 | 06:25 pm
Mankind Pharma's Commercial Paper rating (ICRA) A1+ for ₹1,500 Cr was withdrawn by ICRA Limited at the company's request. The ratings for Non-Convertible Debentures (₹5,000 Cr) remain (ICRA) AA+/Stable and Long-term/Short-term fund-based limits (₹1,250 Cr) are reaffirmed at (ICRA) AA+ (Stable) / (ICRA) A1+.
No comments yet. Be the first to comment!
